首页> 外文OA文献 >STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells

【2h】

STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells

机译：sTI-571（甲磺酸伊马替尼）增强了吡咯并-1,5-苯并氧氮杂卓-6（一种新型微管靶向剂）在sTI-571敏感和耐药Bcr-abl阳性人慢性粒细胞白血病细胞中的凋亡功效

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
GREENE LM; KELLY L; ONNIS V; G. CAMPIANI; LAWLER M; WILLIAMS DC; ZISTERER DM;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. STI-571 (Imatinib Mesylate) Enhances the Apoptotic Efficacy of Pyrrolo-1,5-Benzoxazepine-6,a Novel Microtubule-Targeting Agent,in Both STI-571-Sensitive and -Resistant Bcr-Abl-Positive Human Chronic Myeloid Leukemia Cells [J] . Lisa M.Greene, Liam Kelly, Valeria Onnis The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 2007,第1期

机译：STI-571（甲磺酸伊马替尼）增强了新型微管靶向剂Pyrrolo-1,5-Benzoxazepine-6（对STI-571敏感和耐药的Bcr-Abl阳性人慢性粒细胞白血病细胞）的凋亡功效。
2. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells. [J] . Bright SA, Greene LM, Greene TF, Biochemical Pharmacology . 2009,第3期

机译：新型吡咯并-1,5-苯并x庚因PBOX-21可增强STI571（甲磺酸伊马替尼）在人类慢性粒细胞白血病细胞中的凋亡作用。
3. Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisis. [J] . Koh LP, Hwang WY, Chuah CT, Bone marrow transplantation . 2003,第4期

机译：甲磺酸伊马替尼（STI-571）与非清髓性干细胞移植同时使用不会损害植入，并在急诊危机中的慢性粒细胞白血病患者中导致细胞遗传学缓解。
4. Proteomic Analysis of the Cytoskeleton Regulation in Chronic Myelogenous Leukemia Cells JURL-MK1: Effect of Imatinib Mesylate Treatment [C] . Petr Halada, Katerina Peslova, Dana Grebenova, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：慢性髓性白血病细胞Jull-MK1中细胞骨架调控的蛋白质组学分析：伊马替尼甲磺酸盐处理的影响
5. Influences on physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia patients. [D] . Iyer, Shrividya Sethuraman. 2003

机译：对慢性期慢性粒细胞白血病患者甲磺酸伊马替尼的医师推荐的影响。
6. Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia – Cancer and leukemia group B study 10107 [O] . MEIR WETZLER, KATHLEEN A. DONOHUE, OLATOYOSI M. ODENIKE, -1

机译：伊马替尼耐药的慢性髓细胞性白血病患者与甲磺酸伊马替尼联合使用奥美林森（G3139； Genasense）的可行性–癌症和白血病B组研究10107
7. STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells [O] . Greene Lisa M, Kelly Liam, Onnis Valeria, 2007

机译：STI-571（甲磺酸伊马替尼）在对STI-571敏感和耐药的Bcr-Abl阳性人类慢性粒细胞白血病细胞中均增强了新型微管靶向剂pyrrolo-1,5-benzoxazepine-6的凋亡作用

STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells

著录项

引文网络

相似文献

相关主题

期刊订阅